Science Explorer Back to mapMap
Discussion
Company · Carlsbad · United States

CrossLife Technologies (United States)

crosslifetech.comROR OpenAlex
Research works
64
▲ 368% vs 2018-21
Citations
1.5k
23.7 per fractional work
Top-10% rate
4.3%
all institutions 10.0%
Open access
21%
world 40%
International
16%
world 18%
CrossLife Technologies (United States)

Not ranked overall: CrossLife Technologies (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does CrossLife Technologies (United States) work in?

In all years, 68% of research at CrossLife Technologies (United States) is in Life Sciences, 17% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (66%), Medicine (16%), Engineering (3%). It does 3.7× the world's share of Life Sciences.

Life Sciences: 44 fractional works · 68.2% of its workBiochemistry, Genetics and Molecular Biology: 43 fractional works · 66.4% of its workMolecular Biology: 30 fractional works · 47.0% of its workCancer Research: 8 fractional works · 12.6% of its workGenetics: 3 fractional works · 5.0% of its workBiotechnology: 0 fractional works · 0.8% of its workBiophysics: 0 fractional works · 0.7% of its workAgricultural and Biological Sciences: 1 fractional works · 0.8% of its workPlant Science: 0 fractional works · 0.5% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.3% of its workNeuroscience: 0 fractional works · 0.7% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.7% of its workImmunology and Microbiology: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.1% of its workHealth Sciences: 11 fractional works · 16.6% of its workMedicine: 11 fractional works · 16.5% of its workOncology: 4 fractional works · 5.5% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.2% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.1% of its workEpidemiology: 1 fractional works · 1.2% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 0.8% of its workGenetics: 1 fractional works · 0.8% of its workNeurology: 0 fractional works · 0.8% of its workInfectious Diseases: 0 fractional works · 0.7% of its workPhysiology: 0 fractional works · 0.6% of its workHematology: 0 fractional works · 0.6% of its workImmunology and Allergy: 0 fractional works · 0.4% of its workHepatology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.4% of its workHealth Professions: 0 fractional works · 0.1% of its workPhysical Sciences: 7 fractional works · 10.5% of its workEngineering: 2 fractional works · 3.1% of its workBiomedical Engineering: 1 fractional works · 1.5% of its workElectrical and Electronic Engineering: 1 fractional works · 1.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 1 fractional works · 2.3% of its workEcology: 1 fractional works · 2.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemistry: 1 fractional works · 2.2% of its workOrganic Chemistry: 1 fractional works · 1.5% of its workSpectroscopy: 0 fractional works · 0.8% of its workComputer Science: 1 fractional works · 2.2% of its workComputational Theory and Mathematics: 1 fractional works · 1.6% of its workComputer Networks and Communications: 0 fractional works · 0.3% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnergy: 0 fractional works · 0.5% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 0.5% of its workMaterials Science: 0 fractional works · 0.3% of its workMaterials Chemistry: 0 fractional works · 0.3% of its workSocial Sciences: 3 fractional works · 4.8% of its workSocial Sciences: 1 fractional works · 2.2% of its workSafety Research: 1 fractional works · 1.6% of its workGender Studies: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 1 fractional works · 1.0% of its workOrganizational Behavior and Human Resource Management: 1 fractional works · 1.0% of its workDecision Sciences: 0 fractional works · 0.8% of its workInformation Systems and Management: 0 fractional works · 0.8% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.6% of its workEconomics and Econometrics: 0 fractional works · 0.6% of its workPsychology: 0 fractional works · 0.2% of its workALL ITS WORKCrossLifeTechnologies…64fractional works, all years
Life Sciences68%Physical Sciences10%Health Sciences17%Social Sciences5%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 18 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology4366.4%
    2. Agricultural and Biological Sciences10.8%
    3. Neuroscience00.7%
    4. Immunology and Microbiology00.2%
    5. Pharmacology, Toxicology and Pharmaceutics00.1%
    1. Medicine1116.5%
    2. Health Professions00.1%
    1. Engineering23.1%
    2. Environmental Science12.3%
    3. Chemistry12.2%
    4. Computer Science12.2%
    5. Energy00.5%
    6. Materials Science00.3%
    1. Social Sciences12.2%
    2. Business, Management and Accounting11.0%
    3. Decision Sciences00.8%
    4. Economics, Econometrics and Finance00.6%
    5. Psychology00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does CrossLife Technologies (United States) specialise in?

Where its research is concentrated relative to its size: Molecular Biology takes 11.8× the share of its output that it takes of world research.

  1. Molecular BiologySubfield · 30.3 works12×
  2. Biochemistry, Genetics and Molecular BiologyField · 42.7 works9.6×
  3. Life SciencesDomain · 43.9 works4.5×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at CrossLife Technologies (United States)?

Ranked on the quality score, Federico Katzen and Junko Stevens lead among researchers whose main affiliation is CrossLife Technologies (United States).

  1. 1 Federico Katzen United States · #543,755 worldwide 3.3k citations · 39 works
  2. 2 Junko Stevens United States · #3,081,199 worldwide 6.6k citations · 35 works
All ranked researchers at CrossLife Technologies (United States)

What are the most cited papers from CrossLife Technologies (United States)?

The most cited paper from CrossLife Technologies (United States) is "Characterization of 582 natural and synthetic terminators and quantification of their design constraints" (Ying-Ja Chen, Peng Liu, Alec A. K. Nielsen et al., 2013), with 528 citations. Next come "Genomic mining of prokaryotic repressors for orthogonal logic gates" (411) and "The Cassava Genome: Current Progress, Future Directions" (323).

Most cited papers
#PaperReleasedCitations
1 Characterization of 582 natural and synthetic terminators and quantification of their design constraints Ying-Ja Chen, Peng Liu, Alec A. K. Nielsen et al. · Nature Methods 2 Jun 2013 528
2 Genomic mining of prokaryotic repressors for orthogonal logic gates Brynne C. Stanton, Alec A. K. Nielsen, Alvin Tamsir et al. · Nature Chemical Biology Open access 8 Dec 2013 411
3 The Cassava Genome: Current Progress, Future Directions Simon E. Prochnik, Pradeep Reddy Marri, Brian A. Desany et al. · Tropical Plant Biology Open access 4 Jan 2012 323
4 Whole-Genome Sequencing for Optimized Patient Management Matthew Neil Bainbridge, Wojciech K. Wiszniewski, David R. Murdock et al. · Science Translational Medicine Open access 15 Jun 2011 302
5 The Synthetic Biology Open Language (SBOL) provides a community standard for communicating designs in synthetic biology Michal Galdzicki et al. · Nature Biotechnology Jun 2014 298
All 73 most cited papers, with filters and sorting

Which keywords describe research at CrossLife Technologies (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Gene Expression, Data Analysis, Normalization, Genomic Instability, Targeted Therapy, Cancer Genomics, Mutational Signatures and Quantitative.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Gene Expression9▲ 23×9 topics
  2. Data Analysis6▲ 28×2 topics
  3. Normalization6▲ 127×2 topics
  4. Genomic Instability6▲ 70×2 topics
  5. Targeted Therapy6▲ 41×4 topics
  6. Cancer Genomics5▲ 145×1 topic
  7. Mutational Signatures5▲ 145×1 topic
  8. Quantitative5▲ 62×1 topic
  9. Real-Time PCR5▲ 176×1 topic
  10. Cancer4▲ 4.4×9 topics
  11. Nanoparticles4▲ 4.5×3 topics
  12. Genome Engineering4▲ 95×1 topic
  13. RNA-Guided4▲ 95×1 topic
  14. Biosensors3▲ 8.0×3 topics
  15. Machine Learning3▲ 2.1×5 topics
  16. Glycosylation3▲ 20×2 topics
  17. DNA nanotechnology2▲ 36×1 topic
  18. Self-Assembly2▲ 9.3×1 topic
  19. Membrane Proteins2▲ 19×2 topics
  20. RNA methylation2▲ 45×1 topic
  21. m6A-seq2▲ 45×1 topic
  22. Metastatic Breast Cancer2▲ 53×2 topics
  23. Gene Regulation2▲ 21×4 topics
  24. Signal Transduction2▲ 13×4 topics
  25. Transcriptional Regulation2▲ 13×5 topics
  26. Bioinformatics2▲ 26×3 topics
  27. Monoclonal Antibody2▲ 44×2 topics
  28. RNA Regulation2▲ 28×2 topics
  29. Monoclonal Antibodies2▲ 21×2 topics
  30. Therapeutic Antibodies2▲ 23×2 topics
  31. Epigenetic Regulation2▲ 13×4 topics
  32. Genomics2▲ 8.2×3 topics
  33. Therapy2▲ 13×2 topics
  34. Biopharmaceutical Production2▲ 33×2 topics
  35. Embryonic Stem Cells2▲ 34×2 topics
  36. Gene Therapy2▲ 9.3×3 topics
  37. Bacterial Physiology2▲ 47×1 topic
  38. Chemotherapy-Induced Peripheral Neuropathy2▲ 46×1 topic
  39. DNA Methylation2▲ 20×2 topics
  40. Taxanes2▲ 46×1 topic

Which research topics does CrossLife Technologies (United States) publish most on?

By volume in 2022-now: Context-Aware Activity Recognition Systems, Bluetooth and Wireless Communication Technologies, IoT-based Smart Home Systems and RNA Research and Splicing.

Context-Aware Activity Recognition Systems: 0 fractional worksBluetooth and Wireless Communication Technologies: 0 fractional worksIoT-based Smart Home Systems: 0 fractional worksRNA Research and Splicing0RNA Research and Splicing: 0 fractional worksNuclear Receptors and Si…0Nuclear Receptors and Signaling: 0 fractional worksRNA regulation and disease: 0 fractional worksRNA Interference and Gene Delivery: 0 fractional worksAlzheimer's disease rese…0Alzheimer's disease research and treatments: 0 fractional works
Computer Vision and Pattern RecognitionComputer Networks and CommunicationsElectrical and Electronic EngineeringMolecular Biology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Context-Aware Activity Recognition Systems Computer Vision and Pattern Recognition 0 works
  2. 2 Bluetooth and Wireless Communication Technologies Computer Networks and Communications 0 works
  3. 3 IoT-based Smart Home Systems Electrical and Electronic Engineering 0 works
  4. 4 RNA Research and Splicing Molecular Biology 0 works
  5. 5 Nuclear Receptors and Signaling Cellular and Molecular Neuroscience 0 works
  6. 6 RNA regulation and disease Molecular Biology 0 works
  7. 7 RNA Interference and Gene Delivery Molecular Biology 0 works
  8. 8 Alzheimer's disease research and treatments Physiology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available21.1%not open78.9%

World: 40% of research is openly available.

with international co-authors15.6%domestic only84.4%

World: 18% is written across borders.

How has CrossLife Technologies (United States)'s research output changed?

Output in 2022-2025 was 368% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is CrossLife Technologies (United States) as a percentage of every work published that year, 0.0000051% in 2020.

still counting0.00020%0.00040%0.00060%CrossLife Technologies (United States)0.000020% in 2025200020102020

Fractional works of CrossLife Technologies (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Carlsbad

All research institutions in Carlsbad

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about CrossLife Technologies (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.